Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
29 March 2019 | Story Lacea Loader

No deregistration of students at the University of the Free State (UFS) will be effected until after the Financial Appeals Committee has concluded its process on 5 April 2019.

During a meeting between the university management and the Institutional Student Representative Council (ISRC) today, the following agreement was reached:

  1. The date for the submission of appeals has been extended to Tuesday 2 April 2019 at 12:00. No further extension will be given. The application form for the Financial Appeals Committee has previously been sent to the ufs4life email addresses of all provisionally registered students.
  2. Students who have appealed their National Student Financial Aid Scheme (NSFAS) outcomes will not be deregistered while awaiting the result of the outcome of their appeal.
  3. Verified final-year students who are provisionally registered will not be deregistered. This will be subject to verification by the Financial Appeals Committee. These students must also submit an appeal.
  4. All other categories of students must submit their appeals to the Financial Appeals Committee.

NB: The documentation mentioned above must be submitted to the Student Finance Office as indicated on the financial appeals form sent to students via their ufs4life email address.

The UFS has taken a pro-poor approach to assist students who are academically deserving. With this approach, the university’s fee structure is much less than that of many public institutions of higher learning in the country. Senior students are also supported through a provisional registration process that grants them the opportunity to pay a reduced amount in order to register, enabling them to fully participate in all activities while extension is provided to secure the necessary funding for their studies.

The university has made a number of concessions to ensure that students are not financially excluded during the 2019 academic year. Many of these concessions were raised by the ISRC on behalf of students and was agreed upon by the university management.  

These concessions include:

  1. Students who have confirmed NSFAS funding for 2019 with historic debt, are to secure registration. This has taken place before the announcement on 24 March 2019 by the Minister of Higher Education and Training, Naledi Pandor, that the historic debt of NSFAS students will be settled by the department.

     

  2. Students in the missing middle who received a gap grant in 2018, have been assisted to pay a lesser amount to register fully for 2019.

     

  3. Students with historic debt who are not receiving the gap grant have also been assisted to register for 2019. Acceptable payment plans for these students have been agreed upon with the university’s Student Finance Office.

     

  4. First-time entering students were assisted with a reduced first payment to enable them to register for 2019.

     

  5. Final-year students with historic debt of less than R20 000 who could not have been assisted in any of the above concessions explained above were allowed to register.

     

  6. Students who are provisionally registered and who could not find the necessary financial means, had the opportunity to submit appeals to the Financial Appeals Committee by 29 March 2019 to secure their registration. This committee comprises representatives of the university management, as well as members of the ISRC. This committee is scheduled to meet on 5 April 2019.

The above is evidence of the multi-layered efforts by the university to support academic deserving students as far as it is practically possible in order to avoid financial exclusion. Additionally, the university’s Student Finance Office has since the beginning of the academic year communicated extensively on the process with students who are at risk of being deregistered.  

Historically, less than 0,5% of registered students at the UFS are not able to find the necessary means to secure their registration.

To support students in their academic efforts, all matters pertaining to registration should be concluded by the end of the first term. A cut-off date is set by which all registration processes – including concessions – are to be concluded. This date – 31 March 2019 – has already been set in 2018, which is the result of consultation with all relevant stakeholders, including the IRSC.

This cut-off date has now been extended to Tuesday 2 April 2019 at 12:00.

Released by:

Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393



News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept